Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- GESIURIS HEALTHCARE & INNOVATION FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. · 38 lines · as of Dec 31, 2025 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | GESIURIS HEALTHCARE & INNOVATION FI |
|---|---|
| Roche Holding AG | 5.76 % |
| Johnson & Johnson | 5.33 % |
| AstraZeneca PLC | 4.81 % |
| GSK PLC | 4.74 % |
| Merck & Co Inc | 4.58 % |
| Novartis AG | 4.42 % |
| AbbVie Inc | 4.14 % |
| UnitedHealth Group Inc | 3.42 % |
| Bristol-Myers Squibb Co | 3.34 % |
| Thermo Fisher Scientific Inc | 3.26 % |
| Eli Lilly & Co | 3.23 % |
| Pfizer Inc | 2.91 % |
| Grifols SA | 2.85 % |
| Amgen Inc | 2.81 % |
| Novo Nordisk A/S | 2.59 % |
| Sanofi SA | 2.48 % |
| Medtronic PLC | 2.34 % |
| Elevance Health Inc | 1.84 % |
| Alcon AG | 1.75 % |
| Zoetis Inc | 1.68 % |
| IQVIA Holdings Inc | 1.58 % |
| Regeneron Pharmaceuticals, Inc. | 1.56 % |
| Align Technology Inc | 1.56 % |
| Straumann Holding AG | 1.35 % |
| CSL Ltd | 1.34 % |
| Amplifon SpA | 1.32 % |
| Veeva Systems Inc | 1.28 % |
| Viatris Inc | 1.26 % |
| Abbott Laboratories | 1.25 % |
| Halozyme Therapeutics Inc | 1.22 % |
1 funds, 38 lines read.